Pediatric cerebellar mutism syndrome after posterior fossa tumor surgery: a single-center experience
Purpose The study aims to characterize pediatric cerebellar mutism syndrome (CMS) following posterior fossa tumor surgery, with particular attention to its incidence, clinical course, associated factors, and management. Methods We retrospectively reviewed children aged 3–17 years who underwent posterior fossa tumor resection at a single pediatric neurosurgical center between 2015 and 2025. CMS ascertainment was restricted to postoperative complete mutism. Demographic, clinical, tumor-related, and operative characteristics were compared between children with and without CMS, and management of affected patients was reviewed. Results Among 150 patients, 10 developed CMS (6.7%). Median onset was 1 day after surgery, and median duration of mutism was 41 days. All children with CMS had fourth ventricular tumor involvement. Medulloblastoma (60.0% vs 23.6%; p = 0.020) and urgent surgery (90.0% vs 56.4%; p = 0.047) were more frequent among affected children. The telovelar route was the standard approach to fourth ventricular tumors at our institution (90.9%). Among patients with fourth ventricular tumors treated via the telovelar or transvermian route, CMS occurred in 15.0% and 16.7%, respectively (p = 1.000). Extent of resection did not differ significantly (p = 0.543). Seven children with CMS received pharmacological treatment, most commonly sertraline or benzodiazepines. Conclusions In our institutional experience, CMS occurred in 6.7% of patients and was observed exclusively in children with fourth ventricular involvement. Medulloblastoma and urgent surgery were more frequent among affected patients, although independent effects could not be established. Treatment was individualized, precluding conclusions regarding efficacy.
Authors
- Marek Mandera (ORCID: https://orcid.org/0000-0003-2141-7932)
- Ryszard Sordyl (ORCID: https://orcid.org/0000-0001-5808-011X)
- Karolina Sztuba (ORCID: https://orcid.org/0000-0003-4987-3833)
- Natalia Kardas (ORCID: https://orcid.org/0009-0007-1604-9465)
- Natalia Wyroba (ORCID: https://orcid.org/0009-0004-2230-6403)
Institutions
- Medical University of Silesia (PL)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-20
- DOI
- https://doi.org/10.21203/rs.3.rs-11200298/v1
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- preprint